P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES by C. Grandclement, C. Estoppey, E. Dheilly, M. Panagopoulou, E. Martini, V. Labanca, S. De Angelis, J. Frei, A. Drake, A. Rubod, G. Gudi, V. Udupa, J. Koch Olsen, R. Giovannini, M. A. Doucey, E. Feldman, C. Konto, A. Srivastava, M. Perro, S. Sammicheli

Get full text